Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: June 28, 2023
Racial differences in platelet serotonin polymorphisms in acute coronary syndrome.
Journal: Thrombosis research
Published: June 23, 2020
Low-Frequency Right Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression After Traumatic Brain Injury: A Randomized Sham-Controlled Pilot Study.
Journal: The Journal of neuropsychiatry and clinical neurosciences
Published: April 26, 2019
Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression.
Journal: Psychosomatic medicine
Published: March 12, 2019
Pathological Laughter and Crying and Psychiatric Comorbidity After Traumatic Brain Injury.
Journal: The Journal of neuropsychiatry and clinical neurosciences
Published: August 11, 2015
Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
Journal: Current drug abuse reviews
Published: December 08, 2014
Does acute TBI-related sleep disturbance predict subsequent neuropsychiatric disturbances?
Journal: Brain injury
Published: December 17, 2013
Correlates of apathy during the first year after traumatic brain injury.
Journal: Psychosomatics
Published: December 31, 2012
Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 05, 2012
Diffusion tensor imaging atlas-based analyses in major depression after mild traumatic brain injury.
Diffusion tensor imaging atlas-based analyses in major depression after mild traumatic brain injury.
Journal: The Journal of neuropsychiatry and clinical neurosciences
Published: October 06, 2012
Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations.
Journal: The international journal of neuropsychopharmacology
Published: July 25, 2012
Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
Journal: Psychopharmacology
Published: October 15, 2010
Last Updated: 09/26/2026